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ABSTRACT
Neonatal abstinence syndrome (NAS) in infants presents unique challenges in feeding
and weight gain. The unpredictable clinical manifestations associated with the newborns
withdrawal from exposure to drugs in utero can lead to costly delays in transition of the infant
out of the Neonatal Intensive Care Unit (NICU).The purpose of this review of literature was to
explore feeding positions and nutritional intake with the greatest impact on weight gain in infants
with neonatal abstinence syndrome (NAS) following delivery. The secondary purpose was to
compare the clinical manifestations of infants with NAS that influence nutritional intake and
their relationship to length of time and cost of stay in the NICU. A review of literature was
performed using multiple databases. Articles focusing on feeding position and nutrition intake
were identified for interventions to effectively promote weight gain, while reducing clinical
manifestations common in infants with NAS. Articles exploring improved feeding and weight
gain in infants with NAS and reduced length of stay in the NICU were also synthesized for cost
reductions to the facility. Results from 12 studies comparing various feeding positions that
optimized nutrition, and reduced negative clinical manifestations in infants with NAS were
synthesized for content relevant to the research questions. Results suggest a relationship between
placing infants in the c-position, and side-lying position to reduce sensory stimulation, with
reducing clinical manifestations for infants actively experiencing withdrawal symptoms from
NAS. Providing chin and cheek support as needed, decreasing eye contact during feeding
periods, and providing darker quiet environments all play an important role in allowing infants
with NAS to optimize their weight gain. As previously stated, to manage nutritional intake and
optimize weight gain, reduction of clinical manifestations through pharmacological and nonpharmacological interventions must be actively incorporated into the infants’ plan of care.
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INTRODUCTION

Neonatal abstinence syndrome (NAS), in conjunction with the opioid epidemic, has seen
a successive incremental rise in the United States (US) in the past 20 years, with an increase of
300% from 1.5 hospital births in 1999 to 6 per 1,000 hospital births as of 2013 (Ko et al., 2016).
This is the equivalent of one opioid dependent infant born every 25 minutes (“Dramatic
Increases in Maternal”, 2019). The treatment of NAS in infants born addicted often involve
pharmacologic and non-pharmacological therapies to manage the individualized clinical
manifestations. Clinical manifestations include central nervous system deficits such as
irritability, autonomic dysfunction, and gastrointestinal signs such as excessive sucking, reduced
quality and quantity of feeding resulting in poor weight gain, vomiting, and loose stools (Logan,
Brown, Hayes, 2013). Interventions aimed at reducing the negative effects of addiction involve
consistent care regimens that promote weight gain and growth, while minimizing CNS
disturbances. In most instances, a multidisciplinary approach is instituted using drug therapy and
scheduled care routines, however implementation of care related to feedings can be inconsistent
and vary between health care providers.
The use of pharmacological agents to reduce the severity of CNS clinical manifestations
in infants with NAS is well established. However, interventions aimed at feeding methods to
improve digestion and increase nutrition levels have not been adequately studied in the context
of overall weight gain. According to a study conducted by Wachman, Byun, & Philipp (2010),
breastfeeding rates among opioid-dependent women were low, with 75% of eligible women
electing not to breastfeed. Colostrum and breast milk via breastfeeding in comparison to high
calorie formula via bottle feeding warrants further exploration in relation to weight gain and
nutrition intake for infants with NAS. Equally important is the reduction of clinical
1

manifestations interfering with nutritional intake and proper positioning of infants with NAS
during feeding, with regards to breast-feeding or formula feeding methods.
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PROBLEM
There are many physiologic and psychosocial causes of failure to thrive that can
potentially affect an infant’s weight. Failure to thrive is defined as “a state of undernutrition due
to inadequate caloric intake, inadequate caloric absorption, or excessive caloric expenditure. In
the United States, unintentional weight loss and poor nutritional intake is prevalent in 5 to 10
percent of children in primary care settings” (Cole & Lanham, 2011).
Physiologic causes of failure to thrive can include, damage to the brain or central nervous
system, anemia, metabolic disturbances, chronic infections, cardiovascular or pulmonary
disturbances, organ dysfunction, hormone dysfunction, or low birth weight (Failure to thrive,
2019). Psychosocial causes can include, psychological, social, or economic problems within the
family dynamic. Additionally, “emotional or maternal deprivation, substance abuse, or lack of
knowledge about proper feeding techniques are also related to nutritional deprivation” (Pediatric
Poor Growth, 2019). Often times, the specific cause of failure to thrive cannot be determined.
However, infants affected by NAS have unique concerns regarding weight gain.
Common clinical manifestations that impact infants affected by NAS include diarrhea, vomiting,
irritability, inadequate nutrition, leading to poor weight gain. Clinical manifestations associated
with infants born with NAS present challenges to improving feeding patterns and styles,
promoting weight gain, and ultimately meeting neonatal milestones, to transition out of the
Neonatal Intensive Care Unit (NICU).
The research question in this literature review focused on the socio-economic factors to
identify, promote, and implement efficient feeding positions and styles, as well as quality of
nutritional intake for infants with NAS in order to decrease overall time spent in the NICU, and
cost.
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PURPOSE
The purpose of this literature review was to examine current research regarding factors
that had the greatest impact on weight gain in infants with NAS following delivery, with respect
to various feeding positions and styles, and the quality of nutritional intake.
The outcome of this review was to understand how interventions can be implemented to
decrease the amount of central nervous system disturbances to prevent, maintain, and improve
overall weight gain, and the health of infants affected by NAS. Additionally, this review
explored various socio-economic factors, to identify, promote, and implement interventions that
potentially lead to an overall decrease in time and cost spent in the NICU. Sufficient evidence
exists to suggest that increased weight gain is correspondent with shorter duration in the NICU.
However, more support is needed to determine how these various feeding positions, and quality
of nutritional intake, whether it be breast milk or formula, promote greater overall health,
increased weight gain, and decreased overall time spent in the NICU.
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METHOD
A literature review was performed using research articles from 1999 to present, regarding
factors that have the greatest impact on weight gain in infants with NAS associated with feeding
positioning, and styles, quality of nutritional intake, and reduction of clinical manifestations. The
focus was also to relate to various socio-economic factors to identify, promote, and implement
interventions that will potentially lead to an overall decrease in time and cost spent in the NICU.
Databases used to search for articles included Cumulative Index to Nursing & Allied Health
Literature (CINAHL), Elton B. Stephens Co. (EBSCOhost), Education Resources Information
Center (ERIC), Medical Literature Analysis and Retrieval System Online (Medline), and
PsycINFO databases. Searches used a combination of the following terms: Neonatal abstinence
syndrome*, clinical manifestations*, symptoms*, benefit*, NICU*, weight gain*, feeding*,
nutrition*, high-calorie formula*, breast feeding*, CNS disturbances*, vomiting*, irritability*,
diarrhea*, cost*, and duration*. Inclusion criteria consisted of 1) published research in English,
2) positions and styles of feeding approach, quality of nutrition, and 3) identified interventions
effectively promoting weight gain, while reducing clinical manifestations common in infants
with NAS.
The data was conformed into tables that synthesized the relationship between the various
feeding positions, and styles, as well as the quality of nutrition related to the reduction of clinical
manifestations in infants with NAS. Any additional information on NAS based on reduction of
clinical manifestations, reduced duration of stay in the NICU, and cost-effectiveness, was tabled
based on the obtained data. The data was used to reveal evidence that could be used to develop
guidelines for promoting overall weight gain, and the reduction of clinical manifestations in
infants with NAS.
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BACKGROUND
Neonatal abstinence syndrome (NAS), is the result of behavioral and physiological
clinical manifestations that an infant may experience while withdrawing from narcotics (opioids)
and other pharmacologic agents from exposure in utero (Rojan, 2017). Though there are
recurring clinical manifestations that occur throughout most cases of NAS, the presentation of
NAS is unpredictable, and infants will display individualized manifestations dependent upon the
severity of withdrawal, type of drug, and age of the infant (MacMullen, Dulski & Blobaum,
2014).
There are two major types of NAS (MacMullen, Dulski & Blobaum, 2014). Prenatal
NAS is widely recognized, and is due to the prenatal maternal use of substances. Withdrawal
symptoms will occur once the placenta no longer has access to the substance provided during
pregnancy. Common pharmacological agents used during pregnancy that are implicated in
prenatal NAS consist of: opiates, barbiturates, stimulants such as cocaine, sedatives, ethanol,
marijuana, and nicotine (MacMullen, Dulski & Blobaum, 2014). Postnatal NAS occurs when
there is an abrupt discontinuation of analgesia, such as fentanyl or morphine. It usually occurs
after prolonged drug exposure for post-procedure pain management and/or sedation. However,
chronic opioid exposure is the most common source of NAS (MacMullen, Dulski & Blobaum,
2014).
Maternal substance abuse is a preventable cause of mental, physical, and psychological
problems in infants and children, which can lead to classification of prenatal NAS. Drug abuse in
pregnancy, and neonatal psychomotor behavior consistent with withdrawal from opiate and
polydrug withdrawal is currently a significant clinical and social problem. An estimated average
of 5.4% of pregnant women between 15 to 44 years of age used illicit drugs in 2012-2013. The
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highest rate occurred in those 15to 17 years of age, (14.6%), followed by women 18 to 25 years
of age (8.6%), and those between 26 to 44 years (3.2%) (“Substance Use and Mental Health
Estimates”, 2014).
Postnatal NAS occurs when an abrupt discontinuation of opioid analgesia occurs, usually
after prolonged drug exposure. In the Neonatal Intensive Care Unit (NICU), fentanyl is the most
commonly administered analgesic. This is a potent, rapid acting, synthetic opioid with a relative
lack of hemodynamic side effects. Fentanyl and morphine have shown to produce a high rate of
opioid withdrawal when administered to critically ill infants. Tolerance and withdrawal
symptoms may occur after 5 or more days of continuous infusion of fentanyl, and may occur
more often with fentanyl than morphine (Hamdan, 2017).
Common opiates and narcotics associated with NAS include: Codeine, fentanyl, heroin,
methadone, meperidine, oxycodone, morphine, hydromorphone, butorphanol, pentazocine,
propoxyphene, chlordiazepoxide, buprenorphine, barbiturates, caffeine, cocaine, selective
serotonin reuptake inhibitors, antihistamines, ethanol, marijuana, nicotine, phencyclidine,
meprobamate, glutethimide, ethchlorvynol, diazepam and lorazepam (Hamdan, 2017).
Drugs are transferred from the mother to the fetus via the placenta through active
transport which requires energy to move fluids into the cell. Passive diffusion requires no energy
for movement. Pinocytosis, moves fluid by invagination of the cell membrane. The ease of
transport depends on the size of the drug molecule, its lipophilicity, the pKa (acid ionization
constant) of the compound, and the pH of the blood. During delivery of the fetus, the passage of
the drug is interrupted, resulting in the development of a withdrawal symptom in the neonate. It
is theorized that withdrawal can cause molecular alterations that may produce systemic,
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behavioral, and cognitive symptoms. However, the mechanisms of withdrawal in a neonate are
poorly understood (MacMullen, Dulski & Blobaum, 2014).
Women undergo many physiologic changes throughout their pregnancy. Examples of
common physiologic changes that new mothers may face include nausea, vomiting, sensitivity to
odors, gastric reflux, and constipation. This pregnancy-related constipation is the result of
decreasing peristalsis in the gastrointestinal tract. Peristalsis is the involuntary wave-like
movement that moves food throughout the gastrointestinal tract (Peristalsis, 2019). “Smooth
muscle relaxation and decreased peristalsis occur related to the influence of progesterone.
Elevated progesterone levels cause smooth muscle relaxation, which results in delayed gastric
emptying and decreased peristalsis” (Kyle & Ricci, 2009).
Many women use some type of drug, substance, or medication during pregnancy, and
often times don’t recognize or understand the effects that these substances may have on their
developing fetus. With decreasing peristalsis throughout the gastrointestinal tract, the rate of
absorption for these substances is prolonged, and therefore poses a greater risk for negative
teratogenic effects. Though clinical manifestations are individualized for each infant affected by
NAS, there are general effects that will present themselves due to generalized use of drugs,
substances, or medications during pregnancy. These general effects include, but are not limited
to: interfering with normal fetal development, damaging the infant’s organs, damaging the
placenta and putting the infant’s life at risk, increasing the risk of miscarriage, or bringing on
premature labor (Pregnancy- medication, drugs, and alcohol, 2012). Bowel function and rooting
in the infant are impaired as a result of use of substances during pregnancy. NAS infants lose the
drive to root, or the will to suckle, and have impaired bowel function, resulting in lethargy,
which can lead to poor weight gain.
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As previously stated, NAS is individualized, and infants will present with varying
manifestations. However, there are common manifestations that are recognized and associated
with infants experiencing NAS. The manifestations exhibited are heavily dependent upon the
type of drug used during pregnancy, as well as the amount of exposure the fetus had in utero.
The effect of drugs on body systems is influenced by the type of drug, the combination of drugs,
the amount and frequency of use, the trimester in which the drug is used, the timing of
withdrawal, and the genetic susceptibility of the fetus/neonate (MacMullen, Dulski & Blobaum,
2014). Infants exposed to opioids in utero are likely to present with manifestations such as:
hyperirritability, GI dysfunctions such as excessive sucking, poor feeding, regurgitation, and
diarrhea. They may also experience tremors, high-pitched crying, increased muscle tone,
seizures, nasal congestion, hyperthermia, and tachypnea. Unfortunately, it is not widely known
how healthcare professionals and those caring for infants with NAS can decrease GI
disturbances, and increase opportunities for weight gain. Increased awareness among healthcare
professionals is essential when caring for infants with NAS in relation to feeding quality, and
positioning, to decrease the clinical manifestations related to poor weight gain.
Infants exposed to cocaine in utero may not experience any significant withdrawal
syndromes due to the short period of time in which a withdrawal related to cocaine may occur.
Similarly, infants exposed to benzodiazepines may not experience a withdrawal syndrome.
Though Cannabis/Marijuana is a substance that has been known to be used during pregnancy, the
current effects of Cannabis/Marijuana on the infant, and infant feeding are not yet fully
understood. Alcohol exposed infants may present with hyperactivity, central nervous system
(CNS) dysfunction, fetal alcohol syndrome (FAS), jitteriness, irritability, hyperreflexia,
hypertonia, poor suck, tremors, seizures, poor sleep patterns, hyperphagia, and diaphoresis.
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Infants exposed to selective secretion reuptake inhibitors (SSRIs) may present with jitteriness,
respiratory distress, and sleep disturbances (MacMullen, Dulski & Blobaum, 2014).

Summary
Neonatal abstinence syndrome is an individualized condition that varies between infants.
Though there are many common clinical manifestations, each infant will present with their own
challenges based on type and duration of drug exposure in utero (MacMullen, Dulski &
Blobaum, 2014). Many women use some type of drug, substance, or medication during
pregnancy, and often times don’t recognize or understand the effects that these substances may
have on their developing fetus. It is not widely understood how healthcare professionals can
decrease gastrointestinal disturbances and other manifestations, while increasing opportunities
for weight gain.
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RESULTS
Twelve studies related to neonatal abstinence syndrome and reduction of clinical
manifestations were included in this review of literature. All studies were published in the past
twenty years. Seven articles provided follow-up data on previously conducted cohort studies, one
case study was included, one mixed-methods pilot study was included, one article included a
focus group methodology, one article was composed of a case series, and one prospective cohort
study was also included. Mixtures of both qualitative and quantitative studies were included in
this literature review.
Neonatal Abstinence Syndrome and Related Outcomes
The literature review revealed major themes pertaining to neonatal abstinence syndrome
and the reduction of clinical manifestations to optimize weight gain in infants with this
condition. Studies described self-reported data trends and outcomes related to breastfeeding
promotion, rooming-in promotion, pharmacological interventions, and non-pharmacological
interventions.
Breastfeeding Promotion
Seven studies focused on the promotion of breastfeeding by mothers whose infants are
affected with neonatal abstinence syndrome, so long as there are no outstanding
contraindications, and appropriate therapies have been commenced (Abdel-Latif et al., 2006;
Gottesman, Chang, Feldman, & Ziegler, 2018; Isemann, Meinzen-Derr, & Akinbi, 2011;
MacVicar, Humphrey, & Forbes-McKay, 2017; Pritham, 2012; Pritham, Paul, & Hayes, 2012;
Short, Gannon, & Abatemarco, 2016). In a retrospective cohort study, the effects of breast milk
feeding were assessed in comparison with the severity of neonatal abstinence syndrome in a
population of affected infants. Among 190 infants, the length of stay for those who were
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breastfed was 14.7 days, compared to 19.1 days for those infants who were non-breastfed
(Abdel-Latif et al., 2006). Infants were assessed using the Finnegan Scoring System. The mean
scores for the first 9 days of life were considerably lower in infants with breastmilk intake.
Additionally, the median time to withdrawal occurred considerably later in breastmilk infants
when compared to infants in the formula group (Abdel-Latif et al., 2006).
One infant in a case study was monitored to track tolerance to feedings, daily weight
gain, growth patterns, velocity goals, head circumferences, length measurements, changes in
electrolytes, and implementation of nutrition-related medications. These goals were continually
adjusted to lessen the severity of NAS, and the clinical manifestations associated with it, that the
infant was experiencing. The infant started with transitional formula for intake at the beginning
of the study, then moved to a 20-calorie per ounce term formula, where weight gain (36.2 g/d)
increased. Then, the infant moved to 24- calorie per ounce term formula, where weight (7.4 g/d)
continued to increase. The benefits of breastfeeding for this vulnerable group outweigh any of
the potential risks, granted that the mother is on a stable dose of methadone or buprenorphine,
and is actively involved in an opioid management program (Gottesman, Chang, Feldman, &
Ziegler, 2018).
In a retrospective cohort study, maternal breast milk feedings were associated with
shorter median duration of methadone therapy in both term and preterm infants. Compared to
infants who were formula-fed (median 18.5 days), consumption of maternal breast milk was
associated with shorter length of stay (median 12.5 days) (Isemann, Meinzen-Derr, & Akinbi,
2011).
In a mixed-methods pilot study, thematic analysis generated 5 key themes relating to
breastfeeding support and substance exposure. These themes included: breastfeeding skill and
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knowledge, psychological factors, person-centered approach, environmental modifications, and
postnatal experience on breastfeeding. Breastfed infants in this study had a shorter hospital stay
than infants who were formula-fed (10.8 and 30.0 days, respectively). These infants were also
less likely to require pharmacotherapy, and displayed a less significant course of withdrawal
(MacVicar, Humphrey, & Forbes-McKay, 2017).
In an additional retrospective study, there were statistically significant differences
between infants who were formula-fed and infants who were breastfed in relation to the
commencement of pharmacological treatment. Three infant feeding methods included in this
study (formula, breast, or mixed formula and breast) revealed significant differences in neonatal
abstinence syndrome treatment between formula and breastfed infants, but not between the
formula-fed infants and infants who received a mixture of formula and breastmilk. Opioiddependent women that are actively participating in buprenorphine maintenance therapy were
encouraged to breastfeed, so long as there are no outstanding contraindications present (Pritham,
2012).
Furthermore, in another retrospective study, infants with prenatal exposure to methadone
who were breastfed were discharged home earlier than those infants who were formula-fed. It is
suggested that breastfeeding may be protective for neonates withdrawing from opioids. Overall
breastfeeding is associated with a decreased rate of infant treatment for withdrawal from prenatal
methadone or buprenorphine exposure. Breastfeeding should be permitted and encouraged so
long as the maternal urine drug screen is negative for illicit substances upon admission (Pritham,
Paul, & Hayes, 2012).
Correspondingly, in another retrospective cohort study, it was found that NAS infants
who are breastfed have a significantly shorter length of stay than non-breastfed NAS infants,
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even after controlling for differences in maternal and infant characteristics. Lower rates of
breastfeeding among NAS infants were not unexpected, this tendency could be due to higher
NICU admission rates and/or the physical manifestations more commonly found in this
population, making breastfeeding an additional challenge. However, the act of breastfeeding
plays an additional role in impacting NAS infants, rather than the breast milk intake alone (Short,
Gannon, & Abatemarco, 2016).
Rooming-in Promotion
Three studies described the promotion of mothers and infants rooming-in, and the
benefits that may prevail with infants with NAS.
A retrospective cohort study was conducted to evaluate the effects of rooming-in on the
incidence and severity of NAS among opioid-exposed newborns and on the proportion of
mothers who regain custody of their babies at hospital discharge. Rooming-in was associated
with substantially reduced rates of newborn treatment with morphine, length of morphine
treatment, vomiting, admission to a level II nursery, and length of stay in the hospital. Mothers
who roomed-in were much more likely to retain custody of their newborns. Newborns who
roomed-in were much more likely to be discharged in the custody of their mothers than infants in
other groups. This study found that overall, rooming-in is associated with easing newborns’
transition and promotes better care from the mother (Abrahams et al., 2007).
In a case series, a rooming-in program was implemented to support close uninterrupted
contact between opioid-dependent women and their infants in order to decrease the severity of
NAS scores, lessen the need for pharmacotherapy, and shorten hospital stays. The mean length
of stay was significantly shorter among those in the rooming-in cohort (7.9 days vs 24.8 days).
Rooming-in could potentially reduce bed use and save hospital resources, while preventing
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patients from dealing with negative psychosocial stressors. Rooming-in was also associated with
a decreased need for pharmacotherapy from 88.3% of infants receiving care in the NICU, to only
14.3% of those rooming-in (Newman et al., 2015).
In a retrospective cohort study, the association between breastfeeding and length of
hospital stay among infants diagnosed with NAS was examined. This study found that roomingin and uninterrupted post-partum contact between mother and infant has shown to positively
affect infants by NAS (Short, Gannon, & Abatemarco, 2016).
Pharmacological Interventions
Nine studies discussed the importance of pharmacological interventions in the treatment
regimen for infants with NAS.
In a retrospective cohort study previously discussed, pharmacological treatment began if
Finnegan scores exceeded 8 on 2 occasions or was greater than 10 on 1 occasion. Morphine
commenced for poly-drug and opiate-exposed infants and increased or decreased 10% every 2-3
days to maintain a Finnegan score of less than 8. Phenobarbital was given in addition to
morphine if symptoms were uncontrolled. Overall treatment in the breast milk group was 20
days less than those in the formula group, while the maximum amount of morphine was lower in
the breast milk group (Abdel-Latif et al., 2006).
In the reviewed case study, the infant was given morphine and phenobarbital, and these
medications were titrated accordingly based on Finnegan scores (Gottesman, Chang, Feldman, &
Ziegler, 2018). In the second month of treatment, the infant switched to a 20-calorie per ounce
term formula, and slowly began to wean from phenobarbital and morphine. However, the infant
re-exhibited signs of withdrawal through hyperirritability, and high-pitched cries, therefore
morphine and phenobarbital were continually titrated. The infant continued to show signs of
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withdrawal at month 3. At month 4, phenobarbital was titrated, methadone was added to support
withdrawal, and morphine was removed. At month 5, Finnegan scores were decreasing, while
weight gain was increasing. At month 6, after transitioning to 24-calorie per ounce term formula
with iron, the infant had a weight gain of 7.4 g/d, Finnegan scores were low, and methadone was
discontinued (Gottesman, Chang, Feldman, & Ziegler, 2018). Pharmacological therapy is a
necessity for the treatment regimen in helping infants with NAS.
A retrospective cohort study discussed the factors that impact maternal and neonatal
factors that impact response to methadone therapy for neonatal abstinence syndrome (Isemann,
Meinzen-Derr, & Akinbi, 2011). Infants were scored using the Finnegan Scoring System, and
received methadone per protocol if signs of NAS continued, post-non-pharmacological
management. Infants that required adjunctive therapy with phenobarbital were born of mothers
on higher doses of methadone and had longer lengths of stay compared with infants managed
with methadone therapy alone. Maternal methadone maintenance dose during pregnancy
positively correlated with overall length of stay. There was an inverse relationship between the
amount of mother’s breast milk ingested, and overall length of stay (Isemann, Meinzen-Derr, &
Akinbi, 2011).
A mixed-methods pilot study consisted of an intervention and a control group. The
intervention group received support based on practical breastfeeding advice, promotion of
maternal self-efficacy through encouragement and persuasion, and provision of neonatal selfconsolation techniques within a low-stimuli environment. Of the intervention group, 28%
required pharmacotherapy for severe withdrawal compared with 57% in the control group
(MacVicar, Humphrey, & Forbes-McKay, 2017).
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In a focus group methodology, information was gathered from 12 participants including
NICU nurses and speech therapists through two separate focus group discussions (Maguire,
Shaffer-Hudkins, Armstrong, & Clark, 2018). The study revealed that pharmacological
management with opioid replacement therapy is of value, because it dampens the central nervous
system irritability that leads to disrupted feeding, and therefore to increased mal-adaptive
manifestations and poor weight gain (Maguire, Shaffer-Hudkins, Armstrong, & Clark, 2018).
A retrospective cohort study conducted by Pritham (2012) found that exposed neonates
receiving NAS treatment either through receiving methadone maintenance therapy or
buprenorphine maintenance therapy who were also breastfed began first line therapy with
phenobarbital 1.1 days later and their length of stay was shorter by 9.4 days as compared to
formula-fed neonates or neonates who received formula and breastmilk (Pritham, 2012).
An additional retrospective cohort study consisted of two groups, including: opioiddependent pregnant women on methadone maintenance therapy (MMT), and opioid-dependent
pregnant women on buprenorphine maintenance therapy (BMT). This study found that
benzodiazepine use is a predictor variable for length of treatment for NAS. Neonates exposed to
methadone and benzodiazepines while in utero and who were born at term had significantly
longer length of treatment for NAS when compared with unexposed neonates or to exposed
neonates born prematurely. Also, associated exposure to SSRIs with MMT did not prolong
length of stay. Additionally, neonates exposed to buprenorphine experienced less severe NAS
and shorter length of stay than those exposed to methadone by seven days (Pritham, Paul, &
Hayes, 2012).
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Non-Pharmacological Interventions
Five studies discussed the importance of non-pharmacological interventions in infants
with neonatal abstinence syndrome.
A mixed-methods pilot study evaluated the feasibility of an intervention that included
environmental modifications such as minimizing external stimuli through temperature control,
reduced activity, and regulated noise (MacVicar, Humphrey, & Forbes-McKay, 2017). Infants in
this study were nursed in a shielded cot and canopy to limit exposure to light. The mother was
provided and instructed with consolation techniques including non-nutritive sucking, and loose
swaddling for self-soothing purposes for the infant. The intervention group had higher
breastfeeding rates, and higher confidence in terms of breastfeeding ability than those in the
control group (MacVicar, Humphrey, & Forbes-McKay, 2017).
A focus group methodology by Maguire, Shaffer-Hudkins, Armstrong, and Clark (2018)
showed that neurobehavioral organization plays an important role in successful feeding. Often
times, the baby is not ready to feed when picked up, as a result nursing assessment of feeding
cues were crucial for success when feeding infants with NAS. Additionally, a technique that
achieved feeding goals on a certain day may not work again the next day, requiring continued
trial and error by providers. Swaddling and decreasing environmental stimuli can assist in
calming and comforting the infant during feeding, thereby increasing weight gain in a timely
manner.
Swaddling is one of the few non-pharmacological interventions reported to be effective in
infants with NAS to reduce crying. Swaddling can also decrease startles and sleep arousals,
which leads to increased sleep time and continuity of restful states between feedings. The Cposition holding method was discussed, where the infant is placed on his side, lying on the
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informants’ legs, with arms slightly flexed, keeping the head of the infant slightly elevated by
crossing one leg over the other. Warm baths have been used to calm infants with NAS prior to
feeding as well. Informants in this study emphasized the importance of vertical versus horizontal
rocking to calm the infant. Most informants reported trying all available nipples until they found
the nipple most effective for the infant, and most reported using chin and cheek support as
needed (Maguire, Shaffer-Hudkins, Armstrong, & Clark, 2018) in infants with NAS to increase
amount of time during feeding sessions.
A study randomized to intervention showed that even highly irritable infants can enjoy a
significant reduction in distress by being laid in the prone position. Infants experiencing
withdrawal showed significantly lower levels of distress and lower withdrawal scores when laid
in the prone position compared with similar infants kept supine (Maichuk, Zahorodny, &
Marshall, 1999).
A retrospective cohort study by Short, Gannon, and Abatemarco (2016) showed that
other nonpharmacological interventions both compliment and support the act of breastfeeding,
such as skin to skin contact, and kangaroo care. These positions can lead to optimized weight
gain, and reduction in length of stay, and overall cost spent in infants with NAS having difficulty
feeding (Short, Gannon, & Abatemarco, 2016).
A prospective design, with a random assignment of drug-exposed and non-exposed
newborns to either a control or experimental group, showed that through auditory, tactile, visual,
and vestibular (ATVV) intervention, the drug-exposed experimental group trended toward
greater active sleep. The non-exposed infants who received ATVV intervention had 19% more
alertness during the intervention period than the non-exposed control infants during the same
period of observation. ATVV intervention consisted of a 15-minute procedure, consisting of
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infant-directed talk, continuous throughout the procedure (auditory), 10 minutes of light
stroking/infant massage (tactile), eye-to-eye contact during alert periods (visual), and vertical
rocking of the swaddled infant for 5 minutes post massage (vestibular) (White-Traut et al.,
2002). This intervention is to be conducted prior to feeding intervention to help dampen the
central nervous system, and optimize greater weight gain during feeding periods.

20

DISCUSSION
The studies reviewed in this work provide insight into the common clinical
manifestations of infants with neonatal abstinence syndrome. Research findings revealed the
main outcomes of interventions commonly used in treating infants with NAS, to increase the
opportunity for weight gain. Though the reviewed literature did not have a confirmatory, singular
agreement on the interventions for feeding positions with regard to NAS infant weight gain,
there are main themes that prevailed through multiple articles that were shown to positively
affect outcomes of infants with NAS, while optimizing periods for weight gain.

Breastfeeding Promotion
In the absence of outstanding contraindications, including mothers currently using
methadone maintenance therapy (MMT), buprenorphine maintenance therapy (BMT), or other
appropriate and equal therapies, breastfeeding should be promoted by nurses and healthcare
professionals in efforts to help reduce the severity of neonatal abstinence syndrome, and
optimize weight gain in infants. Several studies had positive correlations with breastfeeding in
comparison to reduction in length of stay, and reduction in likelihood of requiring
pharmacological treatment than infants who were formula-fed (Abdel-Latif et al., 2006;
Gottesman, Chang, Feldman, & Ziegler, 2018; Isemann, Meinzen-Derr, & Akinbi, 2011;
MacVicar, Humphrey, & Forbes-McKay, 2017; Pritham, 2012; Pritham, Paul, & Hayes, 2012;
Short, Gannon, & Abatemarco, 2016).
Infants in multiple articles were assessed using the Finnegan Scoring System (AbdelLatif et al., 2006; Gottesman, Chang, Feldman, & Ziegler, 2018; Isemann, Meinzen-Derr, &
Akinbi, 2011; MacVicar, Humphrey, & Forbes-McKay, 2017; Newman et al., 2015). This
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scoring system is broken into three different systems including, central nervous system
disturbances, metabolic vasomotor/respiratory disturbances, and gastrointestinal disturbances.
Infants are scored with varying numbers of 1-3, dependent on the specific clinical manifestations
in each system. Infants are assessed every 2 hours with the Finnegan Scoring System, while daily
weights are additionally recorded. (“The Assessment and Management”, 1992). During this time,
healthcare providers can continually monitor an infants tolerance to feedings, daily weight gain,
growth patterns, velocity goals, head circumferences, length measurements, changes in
electrolytes, and implementation of pharmacological interventions. Health care providers can
track changes, monitor interventions, and keep detailed records, about feeding and weight gain to
advocate and support infants with NAS and their families.
Management of the clinical manifestations associated with infants exposed to drugs in
utero is useful in promoting feeding and positioning during feeding to ensure weight gain.
Promotion of breastfeeding and skin-to-skin feeding options are of value to feeding infants with
NAS when safe. Though breastfeeding may not be desired, or possible in every case, education
on the benefits and drawbacks directed at the infant’s mother and how and the positive affect on
their infants weight gain and immunologic protection is of value. The literature shows significant
correlation between breastfeeding in infants with NAS and decreasing length of stay in the
hospital, thereby reducing overall cost of stay. Breastfeeding also has been correlated with
decreased need for pharmacological intervention in infants with NAS, and a less severe course of
withdrawal.
Lower rates of breastfeeding among NAS infants is not unexpected and associated with
higher NICU admission rates and/or the physical manifestations commonly found in women
using drug therapy during pregnancy. Healthcare providers can assist in creating an environment
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that is more feasible to breastfeeding, and promote the significance of breastfeeding for
vulnerable populations, such as infants born to women using drugs during pregnancy. Discussion
about the immunologic and protective benefits of breastfeeding can improve both the women’s
health and their infants. Education provided to families about interventions to help control the
physical manifestations of NAS that can be barriers to the breastfeeding process should be
explored. Understanding the mechanics of breastfeeding can be difficult for women after birth of
their child however, healthcare can be prepared and willing to teach proper techniques conducive
to breastfeeding an infant with NAS.

Rooming-in Promotion
Rooming-in has been positively correlated in three articles (Abrahams et al., 2007;
Newman et al., 2015; Short, Gannon, & Abatemarco, 2016). Rooming-in is useful in infants with
NAS that are transitioned from the NICU to the nursery or that are physiologically stable enough
to require less monitoring. The process of rooming-in allows women to stay in the same room
with their infants after delivery, rather than being placed on a different unit. Rooming-in has
been shown to reduce pharmacological treatment, length of stay of infants, overall cost, and
hospital resources. Rooming-in aids in the infants’ transition to extra-uterine life and promotes
better care from the mother. This approach allows the infant to be discharged in the custody of
the mother in a timely manner compared to mother-child dyads not involved in rooming-in.
Inspiring autonomy in women post-partum can be promoted by involving her in the care of her
infant shortly after birth which is easier if the child is in direct proximity. Rooming-in is an
important intervention for both the woman and the infant. Infants born with NAS can benefit
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from multiple family members being present for feeding on demand and immediate soothing of
the clinical manifestations of NAS.

Pharmacological Interventions
Pharmacological interventions are often necessary in infants experiencing NAS. Nine
studies discussed the importance of pharmacological intervention in the treatment regimen for
infants with NAS (Abdel-Latif et al., 2006; Abrahams et al., 2007; Gottesman, Chang, Feldman,
& Ziegler, 2018; Isemann, Meinzen-Derr, & Akinbi, 2011; MacVicar, Humphrey, & ForbesMcKay, 2017; Maguire, Shaffer-Hudkins, Armstrong, & Clark, 2018; Newman et al., 2015;
Pritham, 2012; Pritham, Paul, & Hayes, 2012). Phenobarbital, methadone, and morphine are
consistently used in the treatment regimen for infants with NAS exposed to opioids during
pregnancy, and are used according to a facility’s policy. Other interventions can be used prior to,
and in conjunction with pharmacological interventions. Benefits and drawbacks of drug therapy
in infants with NAS should be explained in depth to families. Pharmacological management with
opioid replacement therapy can reduce the central nervous system irritability that leads to
disrupted feeding, and therefore poor weight gain. Pharmacological intervention has been
associated with decreased length of stay, treatment duration, clinical manifestations and overall
cost.

Non-Pharmacological Interventions
Non-pharmacological interventions should be explored early in the development of the
treatment regimen for an infant with NAS to improve physiologic outcomes, such as weight gain.
Across five separate studies (MacVicar, Humphrey, & Forbes-McKay, 2017; Maguire, Shaffer-
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Hudkins, Armstrong, & Clark, 2018; Maichuk, Zahorodny, & Marshall, 1999; Short, Gannon, &
Abatemarco, 2016; White-Traut et al., 2002), various interventions are discussed to improve
physiologic outcomes for infants with NAS. Minimizing external stimuli, maintaining
temperature control, reducing activity, regulating noise, loose swaddling, limiting exposure to
light, warm baths, C-positioning, and horizontal rocking are examples of non-pharmacological
interventions that had positive outcomes for improved feeding and weight gain. Education about
different methods of consoling infants with NAS to improve length of time during each feeding,
and how to read feeding cues that are different from NAS symptoms can improve weight gain
and decrease the amount of time spent in the NICU or facility. Women and families not educated
about feeding infants with NAS can become easily frustrated and struggle to maintain motivation
to feed their infants. This can lead to less than optimal weight gain and failure to thrive,
increased need for health care services, and costly health care.
Skin to skin contact, chin to cheek support, and ATVV intervention can promote
improved physiologic outcomes in infants with NAS. Non-pharmacological interventions to
increase length of time feeding can assist with lowering levels of distress, optimizing weight
gain, reducing length of stay, and therefore reducing overall cost spent (White-Traut et al.,
2002).
Length of Stay & Overall Cost
Nine articles reflect on the interventions previously mentioned, and their effects on
decreasing length of stay, and therefore, reducing overall cost for families of infants with NAS
(Abdel-Latif et al., 2006; Abrahams et al., 2007; Gottesman, Chang, Feldman, & Ziegler, 2018;
Isemann, Meinzen-Derr, & Akinbi, 2011; MacVicar, Humphrey, & Forbes-McKay, 2017;
Newman et al., 2015; Pritham, 2012; Pritham, Paul, & Hayes, 2012; Short, Gannon, &
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Abatemarco, 2016). “According to The March of Dimes, the length of an average NICU stay
hovers at around 13.2 days. That’s an average cost of $39,600, not factoring in the pregnancy
and birthing costs” (Norsworthy, 2017). Optimizing feeding position and greater nutrient intake
in an infant with NAS to improve weight gain can reduce length of stay in the NICU. It can also
provide an opportunity for autonomy to the woman in caring for her infant and less exposure of
the infant to potential pathogens found in acute care facilities.
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LIMITATIONS
Several limitations were noted in this review of literature. Initial search results revealed
numerous findings on keywords neonatal abstinence syndrome, clinical manifestations, NICU,
weight gain, feeding, nutrition, breast feeding, CNS disturbances, vomiting, irritability, diarrhea,
cost, and duration; however, fewer original research articles remained relevant to the purpose of
this literature review. Search terms were expanded to include keywords symptoms, benefit, highcalorie formula, in order to provide more relevant search results. Inclusion and exclusion vary
between studies and are not defined by concrete widespread criteria used across all articles,
therefore limiting the definitive review of specific topics discussed in this literature review.
Many studies were limited by the lack of research in a wider drug-regimen including nonopiate effects with drugs including amphetamines, and cannabinoids (Abdel-Latif et al., 2006;
Maguire, Shaffer-Hudkins, Armstrong, & Clark, 2018; Maichuk, Zahorodny, & Marshall, 1999;
Pritham, Paul, & Hayes, 2012; Short, Gannon, & Abatemarco, 2016). The limitation on
analyzing effects of a wider range of drugs should be taken into consideration, reflecting that
maternal substance abuse is inclusive of a wide array of narcotics including, but not limited to:
stimulants, barbiturates, opiates, cocaine, sedatives, marijuana, and nicotine. It is estimated that
about five percent of pregnant women will use one or more addictive substances throughout their
pregnancy (“Substance Use in Women”, 2018). With a 300% increase from 1.5 hospital births to
6 per 1,000 hospital births as of 2013, it is evident that we must take a stand as healthcare
professionals to educate and provide resources in the community setting (Ko et al., 2016).
Furthermore, the degree and duration of prenatal narcotic exposure needs to be taken into
consideration. A limitation in many studies in this literature review was the varying degree and
duration of exposure to medications in utero. As previously discussed, NAS is individualized and
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will present differently amongst infants. Therefore, the varying degrees of narcotic exposure, if
known, should be recorded and considered when implementing appropriate interventions.
There are difficulties obtaining information about drug use during pregnancy in suspected
cases due to the fear of incarceration or lawful repercussions. The limited availability of medical
records, and accuracy of documentation to exposure history is a limitation that must be taken into
consideration (Pritham, Paul, & Hayes, 2012). A major limitation in this literature review was
the essence of self-reporting. Often times, women feel judged by healthcare providers for a
history of substance abuse, whether drug therapy was taken throughout pregnancy, or not. This
presents a major challenge for healthcare providers due to the necessity of the data in
implementing appropriate interventions for infants with NAS. For example, cannabis or
marijuana is not fully researched on the effects or the health impact during developmental
milestones of infants in utero. Due to the unreliable nature of self-reporting, the number of
women using marijuana during pregnancy is unknown, though there has been substantial
evidence of statistical significance between marijuana smoking throughout pregnancy, and low
birth weight (“Substance Use in Women”, 2018). Data regarding stimulant use during pregnancy
and the effects on the neonate are not fully understood. There have been effects linked to low
birth weight, smaller head circumference, irritability, hyperactivity, tremors, high-pitched cries,
and excessive sucking at birth (“Substance Use in Women”, 2018) due to stimulant use during
pregancy.
Furthermore, pregnant women are not aware of the damage opioid abuse and prescription
drug therapy during pregnancy can have on the fetus and in some instances the disadvantages to
the fetus are not clearly defined. A limitation in this literature review dealt with the lack of
differentiation between legitimate use of an opioid prescription and maternal opioid abuse
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(Short, Gannon, & Abatemarco, 2016). In-depth information about prescriptive drug regimens
during pregnancy and the teratogenic effects that can result in fetal deprivation of nutrients are
unknown for many drugs. There were also limitations in two studies that focused on the lack of
identification in maternal opioid dependence drug regimens used for treatment, which may have
influenced length of stay, and overall cost spent for the NAS infants time in NICU (Pritham,
Paul, & Hayes, 2012; Short, Gannon, & Abatemarco, 2016). Commencement and duration of
maternal treatment (MMT and BMT) during pregnancy varied greatly, and should also be taken
into consideration.
There was a widespread limitation across articles that used single sites to conduct their
studies. Additionally, the lack of prospective studies became evident while determining articles
to utilize in this literature review.
Lastly, the use of scoring tools to assess NAS withdrawal severity posed challenges when
regarding possible subjective observer bias. This variability in the assessment of NAS changes
implementation of appropriate interventions for infants, and may contribute to greater length of
stay and overall cost, based on the differing interpretations of the condition. Six articles
discussed the use of the Finnegan Scoring System, and/or the Neonatal Abstinence Scoring
System (Abdel-Latif et al., 2006; Gottesman, Chang, Feldman, & Ziegler, 2018; Isemann,
Meinzen-Derr, & Akinbi, 2011; MacVicar, Humphrey, & Forbes-McKay, 2017; Maichuk,
Zahorodny, & Marshall, 1999; Newman et al., 2015).
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Recommendations for Feeding Management to Promote Weight Gain in Infants with NAS
Implementation of Breastfeeding Promotion
Breastfeeding practices should be promoted by healthcare professionals so long as no
outstanding contraindications are present, urine drug screens are negative, and mothers are
actively participating in methadone maintenance therapy, buprenorphine maintenance therapy, or
other appropriate and equally substantial therapies (Pritham, Paul, & Hayes, 2012). Studies in
this literature review have shown that breastfeeding should be encouraged to aid in the reduction
of clinical manifestations regarding neonatal abstinence syndrome, decreasing the need for
pharmacological interventions, reducing length of stay, while also optimizing weight gain in
infants.
Implementation of Rooming-in Promotion
Rooming-in, when appropriate, is an intervention that can be explored regarding the
reduction of clinical manifestations of NAS, and improving weight gain in infants with NAS.
Furthermore, rooming-in has been associated with greater likelihood of retaining custody of the
infant, reduction of pharmacological treatment, length of stay, overall cost, and hospital
resources.
Implementation of Pharmacological and Non-Pharmacological Interventions
Pharmacological interventions are often necessary in the plan of care for infants with
NAS. The use of both pharmacological and non-pharmacological interventions are important in
reducing clinical manifestations of NAS, and therefore increasing opportunities to optimize
weight gain. These interventions are also associated with decreased length of stay, treatment
duration, and overall cost. The use of skin to skin contact, auditory, tactile, visual & vestibular

30

(ATVV) intervention, C-positioning, warm baths, decreased eye contact, and reduced
environmental stimuli should be used frequently in conjunction with pharmacological treatment.
Research
Further research is needed to determine the correlation between dose-related effects of
prenatal narcotic and stimulant exposure, regarding their effects on NAS, and how they affect
clinical manifestations displayed by infants, and infant’s ability to feed in different positions for
weight gain. The effects of non-opiate drugs on infants with NAS is not widely understood.
Though the rise in opiate use during pregnancy is a serious concern, exploring the gaps in
research regarding non-opiate drugs use during pregnancy, and their effects on NAS and infant
feeding and weight gain is of value.
Though the articles included in this literature review were helpful in identifying current
challenges in the management of NAS to improve feeding and weight gain, further qualitative
research from the nurses’ perspective, as well as the perception of the many families, regarding
infant feeding to promote weight gain would be of value to decreasing length of time and cost.
The psychosocial stressors of financial duty regarding severity of NAS, and length of stay were
present in these articles, but should be further explored from a psychological standpoint.
Additionally, the challenges of self-reporting should be researched further, so that proper
interventions may be implemented according to not only clinical manifestations present during
interaction with the pregnant woman, but through quantitative data related to commencement
during gestational age, type of drug, and duration of use.
Education
Successful implement of meaningful feeding interventions to improve weight gain in
infants with NAS include decreasing the clinical manifestations of NAS, optimize weight gain
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with a nutrient dense formula or breast-milk, and reducing the need for pharmacological
treatment. Health care providers are effective in providing communication and consolation
techniques with not only the infant with NAS, but the families of the infant as well, to promote
better bonding patterns, which can improve feeding. Families, if present, can be included during
treatment plans to promote autonomy and to make preparations to care for the infant after
discharge. There is a need for prevention and resource education regarding maternal substance
abuse, as well as prescribed drug therapy throughout pregnancy.
Nursing Practice
Research findings have many implications for nursing practice. The responsibility of not
only a nurse, but a healthcare professional is to stay knowledgeable with current evidence-based
research, and implement the research into their daily practice. It has been proven that nurses who
are caring for infants who are actively experiencing withdrawal symptoms from neonatal
abstinence syndrome can reduce clinical manifestations by laying the infant prone for “tummy
time.” There are many variables to consider when configuring the best feeding practice for infants
with NAS. Often times, feeding position preference can change daily, or during every intervention
period. What works one day, may not work the next, and it’s imperative that nurses find the right
position to soothe the infant, and optimize weight gain. Additionally, there are multiple factors
regarding the fluctuation of severity of neonatal abstinence syndrome. Medications are often
titrated, and environmental factors may not remain the same each day. Therefore, the severity of
NAS can be highly influenced by changes in the environment, and can pose as further challenges
in managing the positioning and intake of infants with NAS.
Regarding feeding, the C-position, where the infant is placed on its side, lying on the
caregiver’s legs, with arms slightly flexed, keeping the head of the infant slightly elevated by
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crossing one leg over the other has been proven to be helpful in the optimization of weight gain.
Additionally, while holding the infant, placing the infant in a side-lying position while supporting
their weight on your chest or stomach, and using chin and cheek support has been especially
helpful in managing nutritional intake for infants with NAS.
Conclusion
Current research regarding breastfeeding promotion, rooming-in, pharmacological and
non-pharmacological treatments has potential to influence nursing practice in the management of
feeding positions, nutritional intake, and weight gain in infants with neonatal abstinence
syndrome. The literature suggests various approaches to feeding techniques are required and can
benefit the infant and post-partum woman through reduction in the severity of clinical
manifestations for infants with NAS, reduced length of stay, reduced cost, and improved weight
gain in infants (Abdel-Latif et al., 2006; Abrahams et al., 2007; Gottesman, Chang, Feldman, &
Ziegler, 2018; Isemann, Meinzen-Derr, & Akinbi, 2011; MacVicar, Humphrey, & ForbesMcKay, 2017; Maguire, Shaffer-Hudkins, Armstrong, & Clark, 2018; Newman et al., 2015;
Pritham, 2012; Pritham, Paul, & Hayes, 2012; Short, Gannon, & Abatemarco, 2016). However,
the correlation between dose-related effects of both opiate and non-opiate exposure in utero on
optimization of weight gain through improved feeding techniques and nutrient intake is unclear.
Though the reduction of clinical manifestations can improve breastfeeding promotion, roomingin, pharmacological and non-pharmacological interventions has been established in the literature,
further research must be conducted to fill the gaps of knowledge on subtopics that aren’t fully
understood. The use of these interventions has been associated with improved health-related
outcomes, and reduced clinical manifestations, leading to optimized weight gain in infants with
NAS.
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APPENDIX A: FIGURE
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Potentially relevant citations identified after screening of databases
(ERIC, CINAHL, PsycINFO, MEDLINE)
(n = 2,461)

Citations excluded due to not
meeting the inclusion criteria
(n = 2,441)

Studies retrieved for more detailed review
(n = 20)

Studies excluded after a more
detailed review due to not
completely meeting inclusion
criteria (n = 8)

Relevant studies included
which met all of the
inclusion criteria
(n =11)

Additional studies reviewed and selected for
use (by hand searching credible reference
citations) meeting inclusion criteria making
total n = 12 for review
Key Search Terms = Neonatal abstinence syndrome*, clinical manifestations*, symptoms*, benefit*,
NICU*, weight gain*, feeding*, nutrition*, high-calorie formula*, breast feeding*, CNS disturbances*,
vomiting*, irritability*, diarrhea*, cost*, and duration*
Limiters = English language, peer-reviewed, published between 1995-2018

Figure 1: Selection Method of Literature
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Table 1: Table of Evidence
Author(s)
Year
Location

Study Design
and Purpose

Sample
Size

Intervention
Protocol

Screening
Measures

Outcome Measures

Key Findings and
Limitations

Abdel-Latif
et al. (2006)
Australia

Retrospective
cohort study

n=190

Infants were
assessed with the
Finnegan objective
Scoring System
before the first feed,
and were assessed
before every feed
for the duration of
admission.

This study included
infants of drug
dependent mothers
admitted to a local
Australian hospital,
between 1998 and
2004.

The mean Finnegan
scores for the first 9
days of life were
considerably lower in
breast milk infants.

Among 190 infants born to drugdependent mothers in New South Wales,
breast milk significantly reduced the
severity of NAS and reduced the length of
hospital stay. The length of stay
among infants who were breastfed was
14.7 days compared to 19.1 days for nonbreastfed infants (p = 0.049).

The purpose
of this study
was to assess
the effects of
breast milk
feeding on
the severity
of neonatal
abstinence
syndrome
(NAS) in a
population of
infants of
drugdependent
mothers who
were at risk
of NAS.

Breast milk
n=85
Formula
n=105

Swaddling, frequent
feeds, and nursing in
quiet environments
were applied from
birth.
Pharmacological
treatment began if
the Finnegan score
exceeded 8 on 2
occasions or was
>10 on 1 occasion.
Morphine was
started at 0.5 mg/kg
per day in 4 divided
doses for polydrug
and opiate-exposed
infants and
increased or
decreased 10%
every 2-3 days to
maintain an average

190 total
consecutive
charts were
reviewed for
maternal and infant
data for this study.
In this specific
hospital, infants
born to drugdependent mothers
were nursed with
their mothers in the
postnatal wards
unless there were
medical or social
contraindications.
All mothers were
encouraged to
breastfeed or
express their milk
for bottle or gavage
feedings unless it
was contraindicated.
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The median time to
withdrawal occurred
considerably
later in breast milk
infants in comparison
to the
formula group (10 vs
3 days; P < .001).
Breast milk infants
were less likely to
require
pharmacologic
treatment for
withdrawal (59.0% vs
79.0%, respectively
P < .001).
6 (7.0%) infants from
the breast milk group,
and 18 (17.1%) from
the formula group
required
phenobarbital in
addition to the
morphine to control
NAS.

The Finnegan scores for the formula
group were consistently higher in the
groups of premature infants and those
who were exposed to polydrug,
methadone, opioid, or maternal
methadone use >80 mg/kg per day. There
was no difference in Finnegan scores
between breastfed infants and those given
breast milk by bottle or gavage tube
within the breast milk group.
Overall treatment in the breast milk group
was 20 days less than those in the formula
group. The maximum amount of
morphine was lower in the breast milk
group. Breast milk was found to be
independently associated with a lessened
need for pharmacologic treatment for
NAS.
Limitations: The majority of the infants in
the study were exposed to opiates, and
only a few were exposed to stimulants
such as cocaine and amphetamines. No
reliable system has been found for

Finnegan score of
<8.

Abrahams et
al. (2007)
Canada

Retrospective
cohort study
The purpose
of this study
was to
evaluate the
effect of
rooming-in
(rather than
standard
nursery care)
on the
incidence and
severity of
neonatal
abstinence
syndrome
among
opioidexposed
newborns and
on the
proportion of
mothers who
retain custody
of their
babies at

n=106
Total
sample of
methadone
or heroin
using
women
n=32
Rooming-in
mothers
n=38
Mothers
who gave
birth at a
local
hospital
before the
rooming-in
program
n=36
Mothers
who
reported
use of
heroin or
methadone,

Phenobarbital was
given to polydrug
opiate-exposed
infants in addition to
morphine if
symptoms were
uncontrolled.
A rooming-in care
program. Routine
care, instruction by
nursing staff on how
to care for the baby
and how to identify
symptoms of NAS.
Parenting skills and
symptoms of NAS
were assessed and
observed. Mothers
were consulted
about their
observation of NAS
in their newborns.

accurately assessing non-opiate effects,
resulting from those such as cocaine,
cannabinoids, and amphetamines.

This study included
women referred by a
local hospital who
were identified as
users of illicit drugs
such as heroin or
methadone, or
whose newborns
were identified as
showing symptoms
of opiate
withdrawal.

Before rooming-in
group: The same
approach to
obstetric care as the
study group, with no
rooming-in. Babies
were kept in a
nursery, separate
from their mothers
during the first week
of life.

Among women who
had had children
previously, fewer in
the rooming-in group
had retained custody
of at least 1 child
(7.7%) than in the
local hospital
comparison group
(15.6%) or the
additional local
hospital group
(22.6%).

Rooming-in was associated with
substantially reduced rates of newborn
treatment with morphine, length of
morphine treatment, vomiting, admission
to a level II nursery, and length of stay in
hospital. Mothers who roomed in were
much more likely to retain custody of
their newborns.

More women in the
rooming-in group
were breastfeeding
(62.5%) than women
in the BCWH group
(7.9%) or the Surrey
group (11.1%) were.

Overall, rooming-in is associated with
easing a newborns’ transition and
promote better care from the mother.

Newborn length of
stay in hospital was
significantly shorter
in the rooming-in
group compared with
the BCWH
comparison group (β-
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Newborns who roomed-in at BCWH were
much more likely to be discharged in the
custody of their mothers than infants in
the other groups.

Limitations:
The subjects were non-randomly
allocated. The subjects didn’t choose their
study groups. The research cannot
exclude the possibility that mothers of
newborns who didn’t show signs of NAS
weren’t included in this study. The
mother-infant dyad was included if the
newborn showed signs of NAS within the
first few days of life.

hospital
discharge.

Gottesman et
al. (2018)
United States
of America

Case Study
The purpose
of this study
was to
expand the
research on a
vulnerable
population in
regard to
neonatal
abstinence
syndrome and
nutritional
challenges
many
neonates
affected by
NAS face.

or whose
babies were
admitted to
a level II
observation
nursery at
an
additional
local
hospital.

n=1 infant

Heroin/methadone
use &/or
observation nursery:
Babies were kept in
a nursery, separate
from their mothers
during the first week
of life.
Morphine was
prescribed as needed
for all 3 groups, and
was titrated to
control symptoms.
Baby N was started
on a transitional
formula initially.
Baby N received a
full nutrition
assessment
(recommendation
for oral feeding
modifications,
adjustment of
formula goal rate,
and evaluation of
growth patterns) on
day 2 of life, and
was reassessed
every 3-5 days while
he remained in the
intermediate
nursery.
Monitoring of
tolerance to
feedings, daily
weight gain,
tracking of growth

coefficient for cohort
membership 1.17,
standard error
0.46, P = .01),
adjusted for maternal
methadone dose at
delivery and
involvement of the
father.

Baby N was
admitted to an
intermediate nursery
in July of 2016, born
at 38 weeks and 4
days’ gestation and
was delivered via Csection. Apgar
scores at 1 minute
and 5 minutes were
recorded, and were
8 and 9 respectively.
Baby N displayed
signs and symptoms
of NAS including:
tremors, jitteriness,
and high-pitched
cries postnatally.
Baby N’s
anthropometric
measurements at
birth were a weight
of 2355 g, length of
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Each month, Baby N
experienced a change
in feeding regimen to
lessen the severity of
NAS, and to meet
goals for
anthropometric
measurements, which
were additionally
recorded each month.
Initially, Baby N
started on a
transitional formula.
At month 2, he
switched to a 20calorie per ounce
term formula, which
lead to a weight gain
of 36.2g/d. He slowly
began to wean from
phenobarbital and
morphine. However,
he re-exhibited signs
of withdrawal

The experience of Baby N displays the
challenges that many infants with NAS
face. He was small for gestational age,
had poor growth, was irritable at meal
times, had an increased length of stay in
the hospital, and showed poor growth.
Though Baby N’s formula goals were
continually adjusted to promote better
weight gain, total gains in length, head
circumference, and weight remained less
than desired.
Breastfeeding has shown to be best for
the infant with NAS. Breastfeeding has
been associated with clinical outcomes
through reductions in the severity of
NAS, duration of treatment, and overall
length of stay. The benefits of
breastfeeding for this vulnerable group
outweigh any of the potential risks,
granted that the mother is on a stable dose
of methadone or buprenorphine, and is
actively involved in an opioid
management program.

velocity goals,
weekly head
circumference and
length
measurements,
monitoring changes
in electrolytes, and
implementation of
nutrition-related
medications
(vitamins, and
minerals).

46.5 cm, and head
circumference of
32.5 cm.

Each month, feeding
regimens were
changed,
anthropometric
measurements were
recorded, Baby N
was continually
assessed by the
Finnegan scoring
system, and
pharmacological
regimens were
added in
accordingly.
Morphine and
phenobarbital were
ordered,
administered, and
titrated based on
Finnegan scores.
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through
hyperirritability and
high-pitched cries,
therefore morphine
and phenobarbital
were titrated
accordingly. At
month 3, Baby N
stayed on the 20calorie per ounce
term formula, and
had a weight gain of
25 g/d. He continued
to show signs of
withdrawal. At month
4, Baby N continued
to receive 20-calorie
per ounce term
formula. He gained
25.7g/d, and
Finnegan scores
remained elevated.
Phenobarbital was
titrated, methadone
was added to support
withdrawal, and
morphine was
removed. At month 5,
Baby N transitioned
to a 24-calorie per
ounce preterm
formula to promote
weight gain. He had a
weight gain of 11.5
g/d. Finnegan scores
were decreasing, and
phenobarbital and
methadone were
titrated. At month 6,

Limitations in NAS research:
Few studies have addressed nutrition
interventions for infants with NAS when
breastfeeding is not an option. There are
limited prospective studies or clinical
trials available to base NAS nutritional
management decisions.

Isemann et al.
(2011)
United States
of America

Retrospective
cohort study

n=142 total
infants

The purpose
of this study
was to
identify
maternal and
neonatal
factors that
impact
response to
methadone
therapy for
neonatal
abstinence
syndrome.

n=128
infants’
postexclusion
n=36
preterm
infants
n=92 term
infants

Pharmacotherapy
for opiate
withdrawal to
identify factors
associated with
favorable response
to methadone
therapy.
Infants were scored
with the Finnegan
Scoring System.
Infants received
methadone per
protocol if signs of
NAS continued.
Post-nonpharmacologic
management
(swaddling, minimal
tactile stimulation,
dimmed lighting and
frequent feeding).
Methadone therapy
started at 0.1 mg kg
orally every 4 hours,
following two
consecutive
Finnegan scores

Inclusion: Most
infants (82%) were
born to mothers that
received prenatal
care. All patients
were managed with
methadone therapy.
Other infants were
born to mothers with
a history of
dependence on
opiates or had urine
drug screen positive
for opiates. All
newborn infants
who were treated
with at least one
dose of methadone
were eligible.
Exclusion: If infants
had no
documentation of
methadone on their
medical record, if
opiates were
administered before
initiating methadone
protocol, if the
methadone protocol
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Baby N remained on
the 24-calorie per
ounce term formula
with iron. He had a
weight gain of 7.4
g/d. Finnegan scores
were low, and
methadone was
discontinued.
Infants that required
adjunctive therapy
with phenobarbital
were born of mothers
on higher doses of
methadone (median
90 (0 to 150) vs 60 (0
to 160) mg per day,
P.0.04) and they had
longer LOS (median
24.5 (12 to 93) vs
13.0 (3 to 43) days,
P<0.0001) compared
with infants managed
with methadone
therapy alone.
Methadone therapy
was initiated at a later
time (P = 0.04), was
accelerated more
frequently (P<0.01)
and was
supplemented with
phenobarbital less
frequently (P=0.002)
in preterm infants
compared with term
infants.

There were no significant differences in
the length of stay between neonates
exposed to methadone in utero compared
with infants that were additionally
exposed to other classes of drugs such as
benzodiazepines (n = 17), barbiturates (n
= 7), cocaine (n = 23), selective serotonin
reuptake inhibitors (n = 17), marijuana (n
= 12), additional opiates (n = 29) or
tobacco (n = 98).
Maternal breast milk feedings were
associated with shorter median duration
of methadone therapy in both term and
preterm infants.
Compared with infants who were
formula-fed, consumption of maternal
breast milk was associated with shorter
length of stay (median 12.5 (3 to 51) vs
18.5 (9 to 43) days, P= 0.01).
Limitations:
Incomplete collection of data from
medical records.
The use of the Finnegan Scoring System
to assess NAS was designed for term
infants, and may not be sensitive in the
assessment of NAS in preterm infants.

above 8. An eightstep tapered dosing
regimen was
followed, which was
guided by Finnegan
scores assessed
every 4 hours.

MacVicar et
al. (2017)
United
Kingdom

Mixedmethods pilot
study

n=53 total
assessed for
eligibility

The purpose
of this study
was to
evaluate the
feasibility
of the
intervention
and to assess
whether a

n=14 total
neonates’
postexclusion
n=7
intervention
neonates

If doses or steps in
the eight-step
tapered dosing
regimen were
skipped, infants
were seen as having
accelerated the
taper. Infants unable
to progress with
continuously
elevated Finnegan
scores were seen as
non-responders, and
were additionally
treated with
phenobarbital at 10
mg/kg orally every
12 hours.
The intervention
group received
support based on
practical
breastfeeding
advice, promotion of
maternal selfefficacy through
encouragement and
persuasion, and
provision of
neonatal selfconsolation

for initial dosing
was not adhered to,
if the infant was
transferred to
another hospital, or
if the infant perished
before the
completion of
methadone tapering.

Maternal methadone
maintenance dose
during pregnancy
correlated with
overall length of stay
(P = 0.009). There
was an inverse
correlation between
the amount of
mother’s breast milk
ingested and length
of stay (B = -0.03, P
= 0.02).

The subjects in this
study were recruited
from a combined
specialist obstetric
or substance abuse
clinic.

On the fifth postnatal
day, 100% (7 of 7) of
the intervention
group was still
breastfeeding
compared with 57%
(4 of 7) of control
participants.

Questionnaire: Thematic analysis
generated 5 key themes relating to
breastfeeding support and substance
exposure: (1) breastfeeding skill and
knowledge, (2) psychological factors, (3)
person-centered approach, (4)
environmental modifications, and (5)
postnatal experience on breastfeeding.

Of the intervention
group, 28% (2 of 7)
required
pharmacotherapy for

There was a demonstrated trend for
continued breastfeeding on the fifth
postnatal day, and intervention

Inclusion criteria
included: Opioid
substation
medication therapy
during pregnancy,
intention to
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Possible bias in initiating MBM therapy
at lower doses, and more aggressive
weaning of infants fed MBM, which may
have contributed to earlier discharge.

future
adequately
powered
randomized
controlled
trial was
warranted.

n=7 control
neonates

techniques within a
low-stimuli
environment. A
scheduled session
with a support
worker was
included, where
collaboration
resulted between
mothers and support
workers to identify
breastfeeding
barriers,
opportunities to
problem solve, and
set individualized,
family-centered
goals. Additionally,
environmental
modifications took
place, such as
minimizing external
stimuli through
temperature control,
reduced activity, and
regulated noise.

breastfeed, > 36
weeks’ gestation,
and over 16 years of
age.

severe withdrawal
compared with 57%
(4 of 7) in the control
group.

Exclusion criteria
included: Those
who were HIV
positive, ongoing
illicit psychoactive
drug or alcohol use,
and had a child
removal order in
force.

The intervention
group also had a
shorter duration of
hospitalization
(mean 10.5 days)
than the control
group (mean
19.4 days).
Collectively breastfed
infants were less
likely to require
pharmacotherapy (3
of 11 breastfeeding
vs 3 of 3 formula
feeding).

participants reported increased
breastfeeding confidence and satisfaction.
The intervention group had higher
breastfeeding rates, and higher confidence
in terms of breastfeeding ability than
those in the control group.
Breastfed infants were less likely to
require pharmacotherapy for neonatal
withdrawal and had a shorter hospital stay
than infants who were formula-fed (10.8
and 30.0 days, respectively).
Maternal experience of health care
practices, attitudes, and postnatal
environment influenced their perceptions
of breastfeeding support.
Breastfed infants displayed a less
significant course of withdrawal.
Limitations:
This study used a single site only, and
there was homogeneity of the population.
The research may not be representative of
other locations, other than Scotland,
where service in health care differs.

The infants were
nursed in a shielded
cot and canopy to
limit exposure to
light. The mother
was provided and
instructed with
consolation
techniques including
non-nutritive
sucking, and loose
swaddling for self-
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soothing purposes
for the infant.
This intervention
lasted from birth up
to and including the
fifth postnatal day.

Maguire et al.
(2018)
United States
of America

Focus group
methodology

n=12 total
n=10 RNs

The purpose
of this study
was to learn
how
caregivers
who are
expert in
feeding
infants with
neonatal
abstinence
syndrome
(NAS)
successfully
feed these
infants during
withdrawal.

n=2
occupationa
l therapists

Severity of neonatal
withdrawal was
assessed every 4-6
hours with the
Finnegan Scoring
System.
Information was
gathered from 12
participants
including NICU
nurses and speech
therapists, through
two separate focus
group discussions.

Data were collected
from participants
working in three
regional hospitals
with Level III
NICUs.
NICU nurses,
occupational
therapists, and
speech therapists
who self-identified
as experienced in
feeding infants with
NAS were included.
Four participants
from each hospital.
All were female,
most (11) worked
full time. Their ages
ranged from 31 to
65 years, years
working in the
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There were 4
overarching themes,
and 8 subthemes that
the data resulted in.
Overarching themes:
(1) Optimal
medication
management
.
(2) Follow the
baby’s cues
and be
flexible with
techniques.
(3) Calm and
comfortable.
(4) Nurture the
relationship.
Subthemes:
(1) Follow the baby’s
cues
(2) Flexibility with
techniques

Results showed that pharmacologic
management with opioid replacement
therapy is very important, because it
dampens the central nervous system
irritability that leads to disrupted feeding.
Sucking behaviors were described as
being disorganized and frantic before
optimal medication management was
achieved. Nurses did not expect to be
successful in feeding infants with NAS
whose signs were not well under control,
and collaborated with the medical team to
re-evaluate the plan of care to achieve
these goals.
Neurobehavioral organization plays an
important role in successful feeding.
Informants reported that the baby is often
not ready to feed when he is picked up, so
nursing assessment of feeding cues was
crucial for success.

NICU ranged from
2-43, and years in
their profession
ranged from 2-43.

(3) Calm the
caregiver
(4) A calm and
comfortable baby
before and during
feeding.
(5) Encourage
caregivers to be
there.
(6) Provide
continuity in
caregiving.
(7) Build parent’s
confidence.
(8) Develop trust and
avoid judgmental
attitudes.

A technique that works one day may not
work the next day, so continued trial and
error is needed.
The informants strongly believed that
anxiety in a caregiver could be felt by the
infant, who was likely to react negatively.
Swaddling and decreasing environmental
stimulation help calm the infant and keep
him comfortable. Swaddling is one of the
few nonpharmacologic interventions that
has been reported to be effective in
infants with NAS to reduce crying.
Swaddling has been known to decrease
startles and sleep arousals, which leads to
an increase in sleep time, and continuity.
Informants also talked about an
intervention called the C position they
adapted for feeding. The infant is placed
on his side lying on the informants’ legs
and arms slightly flexed, keeping the head
of the infant slightly elevated by crossing
one leg over the other.
Warm baths have been used to calm the
infant, whereas others reported that they
start by helping the infant to burp.
Most informants reported that they try all
available nipples until they find the one
that works the best for the infant, and
most reported using chin and cheek
support as needed. Informants used their
gloved finger to find the “sweet spot” on
the palate that helped infants form a good
suck.
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Informants emphasized the importance of
vertical versus horizontal rocking to calm
the infant.
Some informants reported that they often
bottle feed with the infant facing away
from them when the infant cannot tolerate
eye-to-eye contact, to decrease
stimulation associated with eye contact,
and is often successful if the infant opens
his eyes.
Mothers were encouraged to nurture the
relationship by being available for as
many feedings as possible. Mothers were
encouraged to learn infant cues and how
their infant responds to different
interventions.

Maichuk et
al. (1999)
United States
of America

Randomized
to
intervention
The purpose
of this study
was to test
the
hypothesis
that highly
fretful,
narcoticwithdrawing
neonates
experience
less distress

n=48 total
n=25
prone-lying
infants
n=23
supinelying
infants

Subjects in this
study were assessed
for withdrawal
severity with the
Neonatal Abstinence
Scoring System
(NASS), and
through daily caloric
intake.
Infants showing
initial signs of
withdrawal (2
successive NASS
scores of ≥ 5) were
randomly assigned

Subjects were
recruited through
admissions from an
Intermediate Care
Nursery in New
Jersey. All subjects
had urine toxicology
findings that were
positive for heroin
and/or methadone.
Exclusion: Neonates
with sepsis,
congenital
anomalies,
respiratory disease,
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Mean caloric intake
was compared
between groups by
the paired t-test.
Significance was set
at p <0.05.
Supine-lying,
narcotic-withdrawing
infants had
significantly higher
peak withdrawal
severity (NASS)
scores (13.17 ± 2.03)
compared with those
in the prone group

Limitations:
Research needs to include more
information on managing a wider range
of street drugs.
Even highly irritable infants
can enjoy a significant reduction in
distress by being laid prone.
Infants experiencing withdrawal showed
significantly lower levels of distress and
lower withdrawal scores when
laid face down (prone) compared with
similar infants kept face up (supine).
The difference (30%) between the proneand supine- lying groups was clinically
significant and was matched by a
symmetrical increase in feeding by
supine-lying newborns (30%).

in a pronelying position
than
comparable,
supine-lying
neonates.

to the prone (n = 25)
or supine-lying (n =
23) condition.
Infants in the prone
group were
swaddled and laid
belly down for
sleep, while infants
in the supine group
were swaddled and
laid on their backs.

metabolic disorder,
gastroesophageal
reflux, and
intraventricular
hemorrhage.

Per usual practice,
subjects were fed
every 3 to 4 hours,
≤800 calories per
24 hours. Caloric
intake was recorded
at each feeding.
Infant weight
was recorded daily
at 8:00 AM.
Subjects’
withdrawal severity
was assessed
by standard
administration of the
NASS every 2 or 4
hours, depending
on time from onset
of withdrawal.

(10.52 ± 2.08); p <
0.0001.
Mean NASS scores
were also
significantly higher
in the supine-lying
group (7.60 ± 0.70)
compared with the
prone-lying group
(5.11 ± 0.64); p <
0.0001.
Supine-lying subjects
had higher
mean caloric intake
(133 ± 11.2 cal/kg
per 24 hours) than
prone-lying
neonates (100 ± 9.4
cal/kg per 24 hours),
a significant
difference (p <0.001).
There were no
episodes of apnea,
aspiration, or
seizures.

Caloric intake was
summed on a 24hour basis and
divided by the daily
weight (cal/kg per
24 hours). Subjects’
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Limitations:
This study was predestined by the use of
the NASS to assess withdrawal severity.
As designed and administered, the NASS
does not allow for case-blind evaluation
of neonatal withdrawal. In consideration
that withdrawal scoring would be
conducted by the nurses involved in an
affected infant’s care, the NASS
introduces the possibility of observer
bias.
The dose-related effects of prenatal
narcotic and stimulant exposure on
neonatal distress was beyond the scope of
this study. The degree of prenatal narcotic
and cocaine exposure regarding the
infants in this study was not quantified.

Newman et
al. (2015)
Canada

Case series
The purpose
of this study
was to
implement a
rooming-in
program to
support close
uninterrupted
contact
between
opioiddependent
women and
their infants
in order to
decrease the
severity of
NAS scores,
lessen the
need for
pharmacother
apy, and
shorten
hospital stays.

n = 24
NICU
group

n = 21
rooming-in
group

mean and peak
NASS scores,
caloric intake, and
rate of daily weight
gain were
determined.
Opioid-dependent
pregnant women
were assessed
before giving birth,
and were provided
with education and
support.
Psychosocial issues
were addressed in
collaboration with a
community program
developed to
support addicted
mothers. The
mother-infant dyad
was admitted
postpartum to a
private room and
attended by nurses
trained in Finnegan
scoring.

Inclusion:
Women in chronic
opioid therapy, who
delivered single fullterm infants who
were not
apprehended by
child protection
services.
Exclusion:
Women whose
infants were
apprehended at birth
by child protective
services.

The requirement for
oral morphine
therapy for the
neonates in the
rooming-in cohort
was significantly
lower than those
admitted directly to
the NICU (3 of 21
[14.3%] vs 20 of 24
[83.3%]; P < .001).
The mean (SD)
length of stay was
also significantly
shorter among those
in the rooming-in
cohort (7.9 [7.8] days
vs 24.8 [15.6] days; P
< .001).

Women who participated in the roomingin program completed a survey after
discharge. Anonymous responses were
obtained from 14 of the 21 participating
women. On a 5-point scale (1= least
satisfied, 5 = most satisfied), 100% of
women rated their overall experience as a
4 or higher and 86% reported
breastfeeding their infants for an average
duration of 2.5 months.
A decrease in the need for
pharmacotherapy was shown, from 88.3%
of infants receiving usual care in the
NICU to only 14.3% of those rooming-in.
Rooming-in could potentially reduce bed
use and save hospital resources, while
preventing patients from dealing with
negative psychosocial stressors.
The length of stay for subjects in this
study decreased from 24.8 to 7.9 days.

Infants remained
with their mothers
unless persistently
elevated Finnegan
scores deemed it
necessary for
transfer to neonatal
intensive care units
for commencement
of pharmacotherapy.

With the implementation of this program,
a multidisciplinary team had taken the
approach of permitting rooming-in for
infants who were born to opioiddependent women, rather than sending
them straight to the NICU. Additionally,
NICU admission was resorted to only if
pharmacotherapy was required. Within
the first year of implementation, this
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program resulted in decreased length of
stay, and decreased need for
pharmacotherapy, while mothers
favorably rated their experience.

Pritham
(2012)
United States
of America

Retrospective
study
The purpose
of this study
was to
examine the
effect of
infant feeding
methods on
neonatal
abstinence
syndrome.

n=152 total
n=136
opioiddependent
pregnant
women on
methadone
maintenanc
e therapy
(MMT)
n=16
opioiddependent
pregnant
women on
buprenorph
ine
maintenanc
e therapy
(BMT).

Electronic medical
records of all
opioid-dependent
women who were on
methadone
maintenance therapy
(n=136) or
buprenorphine
therapy (n=16)
during pregnancy,
and their neonates.
were reviewed.

Inclusion:
Women on
methadone
maintenance therapy
(n=136) or
buprenorphine
maintenance therapy
(n=16) who labored
and delivered at a
hospital in Maine, or
at an outlying
community hospital
during the same
time-period and
whose neonates
were directly
admitted to the
Neonatal Intensive
Care Unit at the
hospital in Maine
were used for the
study.
Exclusion:
Opioid-dependent
women not on
prescribed
replacement therapy
with methadone
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Exposed neonates
receiving neonatal
abstinence syndrome
treatment either
through receiving
methadone
maintenance therapy
or buprenorphine
maintenance therapy
who were also
breastfed began first
line therapy with
phenobarbital 1.1
days later (p=0.008_
and their length of
stay was shorter by
9.4 days p= .016) as
compared to formulafed neonates or
neonates who
received formula and
breast milk.

Limitations: The NAS scoring tool that
was used to quantify withdrawal severity
somewhat relies on subjective judgement,
and might contribute to a possible source
of bias.
Infant feeding method did not predict
length of stay for neonatal abstinence
syndrome.
However, there were statistically
significant differences between infants
who were formula-fed and infants who
were breastfeed in relation to the
commencement of pharmacologic
treatment such as phenobarbital for
neonatal abstinence syndrome.
The three infant feeding methods
included in this study (formula, breast and
mixed formula and breast) revealed
significant differences in neonatal
abstinence syndrome treatment between
formula, and breastfed infants but not
between the formula-fed infants and
infants fed a mixture of formula and
breastmilk.
Overall, opioid-dependent women who
are actively participating in methadone or
buprenorphine maintenance therapy
should be encouraged to breastfeed, so
long as there are no contraindications
present.

maintenance therapy
or buprenorphine
maintenance therapy
were excluded from
the study.

Pritham et al.,
(2012)
United States
of America

Retrospective
descriptive
study
The purpose
of this study
was to
examine
opioid
replacement
therapy in
pregnancy
and maternal
effects on
neonatal
outcomes
including
length of
hospital stay
for neonatal
abstinence
syndrome.

n=152 total
n=136
opioiddependent
pregnant
women on
methadone
maintenanc
e therapy
(MMT)
n=16
opioiddependent
pregnant
women on
buprenorph
ine
maintenanc
e therapy
(BMT).

A retrospective
chart review was
conducted of
medical records for
opioid-dependent
pregnant women on
MMT or BMT and
their newborns
delivered between
January 1, 2005 and
December 31, 2007.

Neonates less than
28 weeks’ gestation
were excluded
(n=2). The ability of
the placenta to
metabolize
methadone or store
buprenorphine prior
to the third trimester
is not yet fully
understood.
Inclusion:
Women on
methadone
maintenance therapy
(n=136) or
buprenorphine
maintenance therapy
(n=16) who labored
and delivered at a
hospital in Maine, or
at an outlying
community hospital
during the same
time-period and
whose neonates
were directly
admitted to the
Neonatal Intensive
Care Unit at the
hospital in Maine,
were used for the
study.
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Data analysis was
generated using the
Statistical Package
for the Social
Sciences version 19.
The model examined
variables
hypothesized to
affect length of stay,
such as: maternal
methadone dose,
smoking, SSRIs,
benzodiazepines,
alcohol, other
opioids, and
marijuana. In
addition, infant
feeding method was
added because of the
association with
length of stay in other

Maternal:
The mean maternal age was 25.3 years
(standard deviation [SD] 3.9, range 1837).
The demographic characteristics of the
two groups of women, those on
methadone, and those on buprenorphine,
were similar for age, gravidity, parity,
gestational age at first prenatal visit,
number of prenatal visits, reported use of
tobacco, alcohol, and marijuana, and
documentation of prescribed SSRIs
and/or illicit use of benzodiazepines and
other opioids.
Neonates:
The MMT group had significantly smaller
head circumference (p <.03). There were
also differences by group in size for
gestational age (p <.03) with the MMT
group showing more smaller for

Exclusion:
Opioid-dependent
women not on
prescribed
replacement therapy
with methadone
maintenance therapy
or buprenorphine
maintenance therapy
were excluded from
the study.
Neonates less than
28 weeks’ gestation
were excluded
(n=2). The ability of
the placenta to
metabolize
methadone or store
buprenorphine prior
to the third trimester
is not yet fully
understood.

studies. Significance
was set at p  .05.

gestational age infants, and BMT
showing more neonates with larger for
gestational age diagnosis.
Length of Stay:
Maternal methadone dose and
accompanying use of benzodiazepines
increased the length of stay by 8.6 days
while women on MMT who breastfed
their neonates shortened their infants’
length of stay. Infants with prenatal
exposure to methadone who were
breastfed were discharged home earlier
than those infants who were formula-fed.
A positive relationship between maternal
methadone dose and NAS was displayed
in this study.
Benzodiazepine use is a predictor variable
for length of treatment for NAS. Neonates
exposed to methadone and
benzodiazepines while in utero, and who
were born at term had significantly longer
length of treatment for NAS when
compared with unexposed neonates or to
exposed neonates born prematurely.
Associated exposure to SSRIs with MMT
did not prolong length of stay.
Infant feeding method was negatively
related to length of stay, suggesting that
breastfeeding may be protective for
neonates withdrawing from opioids.
Breastfeeding is associated with a
decreased rate of infant treatment for
withdrawal from prenatal methadone or
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buprenorphine exposure. If the maternal
urine drug screen is negative for illicit
substances upon admission, breastfeeding
should be permitted and encouraged for
mothers.
Neonates exposed to buprenorphine
experienced less severe NAS and shorter
length of stay than those exposed to
methadone by seven days.
Limitations:
The study was dependent on the
availability of medical records and the
accuracy of documentation of exposure
history to a number of substances of
interest.
Maternal drug use was mostly determined
by self-report, which may be unreliable,
and should be taken in to consideration.
There was difficulty finding information
in the medical record about
commencement dates regarding opioid
replacement therapy, SSRIs, or
benzodiazepines.
Maternal length of time in addiction
treatment, number of treatment relapses,
time of initiation of MMT or BMT
relative to gestational age and duration of
such therapy, also vary widely, and
should be taken into consideration.
The study did not examine neonatal drug
regimen, and it was not controlled across
all groups.
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Short et al.
(2016)
United States
of America

Retrospective
cohort study
The purpose
of this
populationbased study
was to
examine the
association
between
breastfeeding
and length of
hospital stay
among
infants
diagnosed
with NAS.

n=3,725

Breastfeeding at
discharge was used
to determine
breastfeeding status.
Infant and maternal
characteristics were
compared by
breastfeeding status
and the association
between
breastfeeding and
infant length of
hospitalization was
assessed.

Inclusion:
Single in-hospital
births to resident
mothers in
Pennsylvania
between January 1,
2012 and December
31, 2014.
A total of 20
matching iterations
were performed
using variables such
as child date of
birth, gender, race,
ethnicity, zip code,
facility/hospital
number, gestation,
and birth weight.
Exclusion:
Infants born less
than 34 weeks of
gestation were
excluded to control
for possible
iatrogenic NAS.

Infants who were
breastfed were
significantly more
likely to have a
normal birth weight
(86.9% versus 81.6%,
p < 0.0001) and be
born term (89.6%
versus 86.2%, p <
0.002) than infants
who were not
breastfed.
They were also
significantly more
likely to have
mothers who had
greater than a high
school education
(44.9% versus 32.6%,
p < 0.0001), were
married (25.2%
versus 16.9%, p <
0.0001), and had a
history of prenatal
care (98.8% versus
94.0%, p < 0.0001).
Breastfed infants
were significantly
less likely to have
mothers who smoked
(70.1% versus 81.0%,
p < 0.0001) or
received Medicaid
(66.6% versus 72.6%,
p = 0.0001)
compared to nonbreastfed infants.
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NAS infants who are breastfed have
shown to have a significantly shorter
length of stay than non-breastfed NAS
infants, even after controlling for
differences in maternal and infant
characteristics.
There is an inverse relationship between
breastfeeding and length of hospital stay
and other adverse outcomes among NAS
infants.
The nearly 10% reduction associated with
length of stay for infants who were
breastfed represents as an opportunity for
significant cost savings.
A shortened length of stay may equate to
potential savings of more than $3,000 per
inpatient treatment day.
Lower rates of breastfeeding among NAS
infants are not unexpected and could be
due to higher NICU admission rates
and/or the physical symptoms more
commonly found in this population,
which could make breastfeeding difficult.
The act of breastfeeding, rather than the
actual breast milk itself, is what likely
impacts NAS infants.
Other nonpharmacological interventions
both compliment and support the act of
breastfeeding itself, such as skin to skin
contact, and kangaroo care. Rooming-in
and uninterrupted postpartum contact
between mother and infant has shown to
positively affect infants affected by NAS.

No differences in
NICU admission or
maternal age, race,
ethnicity, or WIC use
were found.
There was a
significant inverse
relationship
between
breastfeeding and
length of stay
(B = -0.085, p =
0.008).

Limitations:
The variability in assessment of NAS
may lead to inaccuracies in the
classification of NAS.
The lack of information regarding both
in-utero exposure and postnatal treatment
for NAS impacts the clinical presentation
of NAS through: Substance(s), timing,
and amount of last maternal use. This
study also did not identify drugs used to
treat maternal opioid dependence,
although treatment may influence length
of stay.
Maternal opioid abuse and the legitimate
use of an opioid prescription was not
differentiated in this study.

White-Traut
et al. (2002)
United States
of America

Prospective
design with
random
assignment of
drug-exposed
and
nonexposed
newborns to
control and
experimental
groups.

n=45 total
drugexposed
newborns
n=21 drugexposed
control
newborns
n=24 drugexposed

ATVV intervention:
A 15-minute
procedure consisting
of infant-directed
talk, continuous
throughout the
procedure
(auditory), 10
minutes of light
stroking/infant
massage (tactile),
eye-to-eye contact

Inclusion:
Sample consisted of
72 nonexposed and
45 prenatally drugexposed 24- to 48hour-old neonates
with a gestational
age of 35 to 41
weeks.
Exclusion:
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Both the drugexposed newborn
group, and the
nonexposed newborn
group were
behaviorally similar
at baseline.
However, the
experimental group
(drug-exposed
newborns)
experienced a

There was a lack of specific data about
breastfeeding practices. There was only
one question used to assess the
breastfeeding status of the infant at
discharge and it did not differentiate
between exclusive breastfeeding, and
mixed feeding of breast milk and formula.
The nonexposed infants who received
the ATVV intervention had 19% more
alertness during the intervention period
than did the nonexposed control infants
during the same period of observation.
The increased arousal of the drugexposed experimental group was
characterized by 13.66% more alertness
than the drug-exposed control infants at
the end of the extended postintervention
period.

The purpose
of this study
was to
compare
responses of
drug-exposed
and
nonexposed
newborns to
auditory,
tactile, visual,
and vestibular
intervention.

experiment
al
newborns.
n=72 total
nonexposed
newborns
n=29
nonexposed
control
newborns
n=43
nonexposed
experiment
al newborns

during alert periods
(visual), and vertical
rocking of the
swaddled infant for
5 minutes post
massage
(vestibular).
Infant behavioral
state (quiet sleep,
active sleep,
drowsy, quiet alert,
active alert, crying,
and indeterminate
state) were
documented.

Infants greater than
48 hours old, had
symptoms of active
withdrawal, were
likely to be
discharged before
completion of the
second ATVV
intervention, had
congenital
malformations, or
required
medications,
treatments, or
intensive/intermedia
te care.

Pulse rate and pulse
waveform were
continuously
recorded with a
pulse oximeter.

significant decrease
in quiet sleep
[F(1,70)=14.83, p=0.
000] and an increase
in alertness
[F(1,70)=5.18, p=0.0
26] during the
intervention.
In the experimental
group during
baseline, a trend
toward an increased
proportion of time
spent in alert states
(p=0.051) was noted.
During the
administration of the
ATVV intervention,
the control group
experienced more
quiet sleep
[F(1,43)=9.04, p=0.0
04] and less
alertness
[F(1,43)=6.13, p=0.0
17].
The increased
arousal of the drugexposed
experimental group
persisted throughout
the immediate post
[F(1,43)=5.04, p=0.0
30] and extended
postintervention
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The drug-exposed control infants
displayed more active sleep than the
nonexposed control infants during the
time that their experimental counterparts
received ATVV intervention
[F(1,49)=9.35, p=0.004].
When compared at baseline, a trend
toward greater active sleep (p=0.092)
was shown for the drug-exposed
experimental group.
The nonexposed experimental infants
displayed greater alertness compared to
the drug-exposed experimental infants
but did not achieve statistical
significance in this study. However, it
supports the previously reported ability
of the ATVV intervention to enhance
both autonomic and behavioral function
in infants.
Drug exposure alone, results in
alterations in infant behavioral state, and
suggests that the ATVV intervention
modified the behavioral responses of
drug-exposed experimental infants
similar to what is seen in nonexposed
experimental infants, which supports the
findings that the ATVV intervention
promotes optimal behavior in drugexposed infants, and is of significant
clinical value.
Limitations:
There was a smaller sample size of
infants, and the research was conducted

[F(1,43)=4.13, p=0.0
49] periods.

over a 12-hour period during early
postnatal adjustments.

The drug-exposed
control infants had
more active sleep
[F(1,49)=7.01, p=0.0
11] and less
alertness
[F(1,49)=7.42, p=0.0
09] than the
nonexposed control
infants.

The group of mothers who participated
may be different from the mothers who
refused to participate.

A strong, significant
correlation between
pulse rate and infant
behavioral state was
found for the
combined group of
nonexposed infants
(r=0.840, p=0.001)
whether they were
assigned to the
control
(r=0.938, p=0.006)
or experimental
group
(r=0.979, p=0.001).
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Self-reports are often unreliable, and were
evident in this study.
Infants were considered “nonexposed” if
maternal and/or infant urine toxicology
was negative, and/or if a history of drug
use during pregnancy was not identified
through medical record screening.
Various lengths of exposure to a wide
range of drugs may have contributed to
affecting behavior.
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